149 related articles for article (PubMed ID: 9186912)
1. Chylomicron/chylomicron remnant turnover in humans: evidence for margination of chylomicrons and poor conversion of larger to smaller chylomicron remnants.
Karpe F; Olivecrona T; Hamsten A; Hultin M
J Lipid Res; 1997 May; 38(5):949-61. PubMed ID: 9186912
[TBL] [Abstract][Full Text] [Related]
2. Quantification of postprandial triglyceride-rich lipoproteins in healthy men by retinyl ester labeling and simultaneous measurement of apolipoproteins B-48 and B-100.
Karpe F; Bell M; Björkegren J; Hamsten A
Arterioscler Thromb Vasc Biol; 1995 Feb; 15(2):199-207. PubMed ID: 7749826
[TBL] [Abstract][Full Text] [Related]
3. Contraceptive steroids increase hepatic uptake of chylomicron remnants in healthy young women.
Berr F; Eckel RH; Kern F
J Lipid Res; 1986 Jun; 27(6):645-51. PubMed ID: 3746133
[TBL] [Abstract][Full Text] [Related]
4. Characterization of chylomicron remnant clearance by retinyl palmitate label in normal humans.
Berr F
J Lipid Res; 1992 Jun; 33(6):915-30. PubMed ID: 1512515
[TBL] [Abstract][Full Text] [Related]
5. Clearance of lipoprotein remnant particles in adipose tissue and muscle in humans.
Karpe F; Humphreys SM; Samra JS; Summers LK; Frayn KN
J Lipid Res; 1997 Nov; 38(11):2335-43. PubMed ID: 9392431
[TBL] [Abstract][Full Text] [Related]
6. Plasma decay of chylomicron remnants is not affected by heparin-stimulated plasma lipolytic activity in normal fasting man.
Berr F; Eckel R; Kern F
J Lipid Res; 1985 Jul; 26(7):852-9. PubMed ID: 4031663
[TBL] [Abstract][Full Text] [Related]
7. Dietary fat and physiological determinants of plasma chylomicron remnant homoeostasis in normolipidaemic subjects: insight into atherogenic risk.
Irawati D; Mamo JC; Slivkoff-Clark KM; Soares MJ; James AP
Br J Nutr; 2017 Feb; 117(3):403-412. PubMed ID: 28215212
[TBL] [Abstract][Full Text] [Related]
8. Delayed chylomicron remnant clearance in subjects with heterozygous familial hypercholesterolaemia.
Cabezas MC; de Bruin TW; Westerveld HE; Meijer E; Erkelens DW
J Intern Med; 1998 Oct; 244(4):299-307. PubMed ID: 9797493
[TBL] [Abstract][Full Text] [Related]
9. Plasma clearance of chylomicrons labeled with retinyl palmitate in healthy human subjects.
Berr F; Kern F
J Lipid Res; 1984 Aug; 25(8):805-12. PubMed ID: 6491526
[TBL] [Abstract][Full Text] [Related]
10. Catabolism of chylomicron remnants in normolipidemic subjects in relation to the apoprotein E phenotype.
Brenninkmeijer BJ; Stuyt PM; Demacker PN; Stalenhoef AF; van 't Laar A
J Lipid Res; 1987 Apr; 28(4):361-70. PubMed ID: 3585171
[TBL] [Abstract][Full Text] [Related]
11. Kinetics of chylomicron remnant clearance in normal and in hyperlipoproteinemic subjects.
Cortner JA; Coates PM; Le NA; Cryer DR; Ragni MC; Faulkner A; Langer T
J Lipid Res; 1987 Feb; 28(2):195-206. PubMed ID: 3572247
[TBL] [Abstract][Full Text] [Related]
12. Differences in apolipoprotein and lipid composition between human chylomicron remnants and very low density lipoproteins isolated from fasting and postprandial plasma.
Björkegren J; Karpe F; Milne RW; Hamsten A
J Lipid Res; 1998 Jul; 39(7):1412-20. PubMed ID: 9684744
[TBL] [Abstract][Full Text] [Related]
13. Postprandial chylomicrons and VLDLs in severe hypertriacylglycerolemia are lowered more effectively than are chylomicron remnants after treatment with n-3 fatty acids.
Westphal S; Orth M; Ambrosch A; Osmundsen K; Luley C
Am J Clin Nutr; 2000 Apr; 71(4):914-20. PubMed ID: 10731497
[TBL] [Abstract][Full Text] [Related]
14. Thyroxine replacement therapy enhances clearance of chylomicron remnants in patients with hypothyroidism.
Weintraub M; Grosskopf I; Trostanesky Y; Charach G; Rubinstein A; Stern N
J Clin Endocrinol Metab; 1999 Jul; 84(7):2532-6. PubMed ID: 10404832
[TBL] [Abstract][Full Text] [Related]
15. Delayed clearance of chylomicron remnants following vitamin-A-containing oral fat loads in broad-beta disease (type III hyperlipoproteinemia).
Hazzard WR; Bierman EL
Metabolism; 1976 Jul; 25(7):777-801. PubMed ID: 181657
[TBL] [Abstract][Full Text] [Related]
16. Competition between chylomicrons and their remnants for plasma removal: a study with artificial emulsion models of chylomicrons.
Oliveira HC; Hirata MH; Redgrave TG; Maranhão RC
Biochim Biophys Acta; 1988 Feb; 958(2):211-7. PubMed ID: 3337836
[TBL] [Abstract][Full Text] [Related]
17. Abnormal metabolism of postprandial lipoproteins in patients with non-insulin-dependent diabetes mellitus is not related to coronary artery disease.
Syvänne M; Hilden H; Taskinen MR
J Lipid Res; 1994 Jan; 35(1):15-26. PubMed ID: 8138716
[TBL] [Abstract][Full Text] [Related]
18. Chylomicron-retinyl palmitate clearance in type I hyperlipidemic families.
Sprecher DL; Knauer SL; Black DM; Kaplan LA; Akeson AA; Dusing M; Lattier D; Stein EA; Rymaszewski M; Wiginton DA
J Clin Invest; 1991 Sep; 88(3):985-94. PubMed ID: 1885783
[TBL] [Abstract][Full Text] [Related]
19. Postchallenge plasma lipoprotein retinoids: chylomicron remnants in endogenous hypertriglyceridemia.
Wilson DE; Chan IF; Buchi KN; Horton SC
Metabolism; 1985 Jun; 34(6):551-8. PubMed ID: 3999977
[TBL] [Abstract][Full Text] [Related]
20. Accumulation of chylomicron remnants in homozygous subjects with familial hypercholesterolaemia.
Mamo JC; Smith D; Yu KC; Kawaguchi A; Harada-Shiba M; Yamamura T; Yamamoto A
Eur J Clin Invest; 1998 May; 28(5):379-84. PubMed ID: 9650011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
